Turning Point Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Turning Point Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$1.50 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.50.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$1.58.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.34.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.14.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$4.80.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$3.85.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.99.
- Turning Point Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$7.31.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.50 10-Q · filed 2022-05-10 | -$3.09 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$4.43 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$5.57 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2021-12-31 | -$1.58 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.93 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$4.07 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$4.80 10-K · filed 2022-02-28 |
| 2021-09-30 | -$1.34 10-Q · filed 2021-11-09 | -$2.49 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$3.21 10-Q · filed 2021-11-09 | -$4.23 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2021-06-30 | -$1.14 10-Q · filed 2021-08-09 | -$1.87 10-Q · filed 2021-08-09 | -$2.88 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$3.36 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2021-03-31 | -$0.73 10-Q · filed 2022-05-10 | -$1.74 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$2.19 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$3.00 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2020-12-31 | -$1.02 10-K · filed 2021-03-01 | -$1.47 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.27 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$3.85 10-K · filed 2022-02-28 |
| 2020-09-30 | -$0.42 10-Q · filed 2021-11-09 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.82 10-Q · filed 2021-11-09 | -$3.43 derived: net income ÷ weighted average shares · filed 2021-11-09 |
| 2020-06-30 | -$0.82 10-Q · filed 2021-08-09 | -$2.47 10-Q · filed 2021-08-09 | -$3.08 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$3.75 derived: net income ÷ weighted average shares · filed 2021-11-09 |
| 2020-03-31 | -$1.69 10-Q · filed 2021-05-05 | -$2.28 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.94 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$3.71 derived: net income ÷ weighted average shares · filed 2021-11-09 |
| 2019-12-31 | -$0.58 10-K · filed 2021-03-01 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.90 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$2.99 10-K · filed 2022-02-28 |
| 2019-09-30 | -$0.63 10-K · filed 2021-03-01 | -$1.32 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$2.54 10-Q · filed 2020-11-12 | -$3.78 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-06-30 | -$0.70 10-K · filed 2021-03-01 | -$2.19 10-Q · filed 2020-08-10 | -$3.81 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$5.27 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-03-31 | -$3.97 10-K · filed 2021-03-01 | -$6.61 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$8.39 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$9.88 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2018-12-31 | -$2.64 10-K · filed 2020-03-18 | -$4.41 derived: net income ÷ weighted average shares · filed 2020-03-18 | -$5.91 derived: net income ÷ weighted average shares · filed 2020-03-18 | -$7.31 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.77 10-K · filed 2020-03-18 | -$3.26 derived: net income ÷ weighted average shares · filed 2020-03-18 | -$4.66 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$1.49 10-K · filed 2020-03-18 | -$2.89 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$1.41 10-K · filed 2020-03-18 | |||
| 2017-12-31 | -$4.97 10-K · filed 2020-03-18 |